Status:
TERMINATED
The Aim is to Estimate the Total Amount of Insulin-producing Cells in the Pancreas by MRI.
Lead Sponsor:
Pfizer
Collaborating Sponsors:
Yale University
Conditions:
Diabetes Mellitus
Eligibility:
All Genders
18-65 years
Phase:
NA
Brief Summary
Assess pancreatic beta cell function using MR imaging.
Detailed Description
The study was terminated on July 31st, 2007. The study was discontinued, as we have not met the primary end point, differentiation between normal volunteers and subjects with type 1 diabetes mellitus....
Eligibility Criteria
Inclusion
- Normal Volunteers
- T1DM and T2DM subjects
Exclusion
- Concomitant severe conditions
Key Trial Info
Start Date :
December 1 2005
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
July 1 2007
Estimated Enrollment :
29 Patients enrolled
Trial Details
Trial ID
NCT00280085
Start Date
December 1 2005
End Date
July 1 2007
Last Update
August 7 2009
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Pfizer Investigational Site
New Haven, Connecticut, United States, 06510